Functional genetic variation in aminopeptidase A (ENPEP): Lack of clear association with focal and segmental glomerulosclerosis (FSGS)

Gene

Volumn 410, Issue 1, 2008, Pages 44-52

  Tonna, Stephen ^a   Dandapani, Savita V ^a   Uscinski, Andrea ^a   Appel, Gerald B ^b   Schlöndorff, Johannes S ^a   Zhang, Kang ^c   Denker, Bradley M ^a   Pollak, Martin R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

DNA sequence analysis; Hypertension; Mutation; Private non conservative allele; Single nucleotide polymorphisms

Indexed keywords

ANGIOTENSIN II; ASPARTIC ACID; ENZYME ANTIBODY; GLUTAMIC ACID; GLUTAMYL AMINOPEPTIDASE;

ADULT; ALBUMINURIA; AMINO TERMINAL SEQUENCE; ARTICLE; BAGG ALBINO MOUSE; BRUSH BORDER; CELL MEMBRANE; CONTROLLED STUDY; DNA SEQUENCE; ENPEP GENE; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENE; GENE FUNCTION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY PROXIMAL TUBULE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BLOTTING, WESTERN; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GLUTAMYL AMINOPEPTIDASE; HUMANS; MALE; MUTAGENESIS, SITE-DIRECTED; POLYMORPHISM, SINGLE NUCLEOTIDE; VARIATION (GENETICS);

MUS;

EID: 40649109513     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2007.11.014     Document Type: Article

References (58)

1. Assmann K.J., van Son J.P., Dijkman H.B., and Koene R.A. A nephritogenic rat monoclonal antibody to mouse aminopeptidase A. Induction of massive albuminuria after a single intravenous injection. J. Exp. Med. 175 3 (1992) 623-635
2. Assmann K.J., van Son J.P., Dijkman H.B., Mentzel S., and Wetzels J.F. Antibody-induced albuminuria and accelerated focal glomerulosclerosis in the Thy-1.1 transgenic mouse. Kidney Int. 62 1 (2002) 116-126
3. Barisoni L., Kriz W., Mundel P., and D'Agati V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J. Am. Soc. Nephrol. 10 1 (1999) 51-61
4. Bogatzki M. On the importance of the renin-angiotensin-aldosterone system in the pathogenesis of renal hypertension. Med. Klin. 59 (1964) 1046-1048
5. Boute N., Gribouval O., Roselli S., Benessy F., Lee H., Fuchshuber A., Dahan K., Gubler M.C., Niaudet P., and Antignac C. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 24 4 (2000) 349-354
6. Brenner B.M., Cooper M.E., de Zeeuw D., Keane W.F., Mitch W.E., Parving H.H., Remuzzi G., Snapinn S.M., Zhang Z., and Shahinfar S. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345 12 (2001) 861-869
7. Collier J.G., Robinson B.F., and Vane J.R. Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme. Lancet 1 7794 (1973) 72-74
8. Conn J.W., Rovner D.R., and Cohen E.L. Normal and altered function of the renin-angiotensin-aldosterone system in man: applications in clinical and research medicine. Ann. Intern. Med. 63 (1965) 266-284
9. Copelovitch L., Guttenberg M., Pollak M.R., and Kaplan B.S. Renin-angiotensin axis blockade reduces proteinuria in presymptomatic patients with familial FSGS. Pediatr. Nephrol. (2007)
10. Corvol P., and Plouin P.F. Angiotensin II receptor blockers: current status and future prospects. Drugs 62 Spec No 1 (2002) 53-64
11. Croog S.H., Kong B.W., Levine S., Weir M.R., Baume R.M., and Saunders E. Hypertensive black men and women. Quality of life and effects of antihypertensive medications. Black Hypertension Quality of Life Multicenter Trial Group. Arch. Intern. Med. 150 8 (1990) 1733-1741
12. Dijkman H.B., Assmann K.J., Steenbergen E.J., and Wetzels J.F. Expression and effect of inhibition of aminopeptidase-A during nephrogenesis. J. Histochem. Cytochem. 54 2 (2006) 253-262
13. Dijkman H.B., Gerlofs-Nijland M.E., van der Laak J.A., Wetzels J.F., Groenen P.J., and Assmann K.J. Podocyte changes after induction of acute albuminuria in mice by anti-aminopeptidase A mAb. Nephron. Exp. Nephrol. 94 3 (2003) e85-e93
14. Forbes J.M., Bonnet F., Russo L.M., Burns W.C., Cao Z., Candido R., Kawachi H., Allen T.J., Cooper M.E., Jerums G., et al. Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria. J. Hypertens. 20 5 (2002) 985-992
15. Fournie-Zaluski M.C., Fassot C., Valentin B., Djordjijevic D., Reaux-Le Goazigo A., Corvol P., Roques B.P., and Llorens-Cortes C. Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension. Proc. Natl. Acad. Sci. U. S. A. 101 20 (2004) 7775-7780
16. Gafford J.T., Skidgel R.A., Erdos E.G., and Hersh L.B. Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides. Biochemistry 22 13 (1983) 3265-3271
17. Gavras H., Brunner H.R., Laragh J.H., Sealey J.E., Gavras I., and Vukovich R.A. An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N. Engl. J. Med. 291 16 (1974) 817-821
18. Gerlofs-Nijland M.E., Assmann K.J., Dijkman H.B., Dieker J.W., van Son J.P., Mentzel S., van Kats J.P., Danser A.H., Smithies O., Groenen P.J., et al. Albuminuria in mice after injection of antibodies against aminopeptidase A: role of angiotensin II. J. Am. Soc. Nephrol. 12 12 (2001) 2711-2720
19. Gerlofs-Nijland M.E., Assmann K.J., van Son J.P., Dijkman H.B., te Loeke N.A., van der Zee R., Wetzels J.F., and Groenen P.J. Epitope mapping of monoclonal antibodies directed to aminopeptidase A and their relevance for albuminuria in mice. Nephron Exp. Nephrol. 94 1 (2003) e25-e34
20. Goto Y., Hattori A., Ishii Y., Mizutani S., and Tsujimoto M. Enzymatic properties of human aminopeptidase A. Regulation of its enzymatic activity by calcium and angiotensin IV. J. Biol. Chem. 281 33 (2006) 23503-23513
21. Ichihara A., Kaneshiro Y., Takemitsu T., Sakoda M., Nakagawa T., Nishiyama A., Kawachi H., Shimizu F., and Inagami T. Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage. J. Am. Soc. Nephrol. 17 9 (2006) 2495-2503
22. Jongeneel C.V., Bouvier J., and Bairoch A. A unique signature identifies a family of zinc-dependent metallopeptidases. FEBS Lett. 242 2 (1989) 211-214
23. Kaplan J.M., Kim S.H., North K.N., Rennke H., Correia L.A., Tong H.Q., Mathis B.J., Rodriguez-Perez J.C., Allen P.G., Beggs A.H., et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 24 3 (2000) 251-256
24. Kaufman L., Yang G., Hayashi K., Ashby J.R., Huang L., Ross M.J., Klotman M.E., and Klotman P.E. The homophilic adhesion molecule sidekick-1 contributes to augmented podocyte aggregation in HIV-associated nephropathy. FASEB J. 21 7 (2007) 1367-1375
25. Kestila M., Lenkkeri U., Mannikko M., Lamerdin J., McCready P., Putaala H., Ruotsalainen V., Morita T., Nissinen M., Herva R., et al. Positionally cloned gene for a novel glomerular protein--nephrin--is mutated in congenital nephrotic syndrome. Mol. Cell 1 4 (1998) 575-582
26. Kretzler M., Koeppen-Hagemann I., and Kriz W. Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised-desoxycorticosterone hypertensive rat. Virchows Arch. 425 2 (1994) 181-193
27. Li L., Wu Q., Wang J., Bucy R.P., and Cooper M.D. Widespread tissue distribution of aminopeptidase A, an evolutionarily conserved ectoenzyme recognized by the BP-1 antibody. Tissue Antigens 42 5 (1993) 488-496
28. Li L., Wu Q., Barnoski B.L., and Cooper M.D. High-resolution genetic map of the human glutamyl aminopeptidase gene (ENPEP). Genomics 43 3 (1997) 380-383
29. Lin Q., Taniuchi I., Kitamura D., Wang J., Kearney J.F., Watanabe T., and Cooper M.D. T and B cell development in BP-1/6C3/aminopeptidase A-deficient mice. J. Immunol. 160 10 (1998) 4681-4687
30. Mentzel S., Assmann K.J., Dijkman H.B., de Jong A.S., van Son J.P., Wetzels J.F., and Koene R.A. Inhibition of aminopeptidase A activity causes an acute albuminuria in mice: an angiotensin II-mediated effect?. Nephrol. Dial. Transplant. 11 11 (1996) 2163-2169
31. Mentzel S., Dijkman H.B., Van Son J.P., Koene R.A., and Assmann K.J. Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice. J. Histochem. Cytochem. 44 5 (1996) 445-461
32. Mentzel S., van Son J.P., Dijkman H.B., Wetzels J.F., and Assmann K.J. Induction of albuminuria in mice: synergistic effect of two monoclonal antibodies directed to different domains of aminopeptidase A. Kidney Int. 55 4 (1999) 1335-1347
33. Migaud M., Durieux C., Viereck J., Soroca-Lucas E., Fournie-Zaluski M.C., and Roques B.P. The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A. Peptides 17 4 (1996) 601-607
34. Mitsui T., Nomura S., Okada M., Ohno Y., Kobayashi H., Nakashima Y., Murata Y., Takeuchi M., Kuno N., Nagasaka T., et al. Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice. Mol. Med. 9 1-2 (2003) 57-62
35. Mogensen C.E. Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment. Scand. J. Clin. Lab. Invest. 36 4 (1976) 383-388
36. Mogensen C.E. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N. Engl. J. Med. 310 6 (1984) 356-360
37. Mulrow P.J., and Ganong W.F. Role of the kidney and the renin-angiotensin system in the response of aldosterone secretion to hemorrhage. Circulation 25 (1962) 213-220
38. Nagase M., Shibata S., Yoshida S., Nagase T., Gotoda T., and Fujita T. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 47 6 (2006) 1084-1093
39. Nahum L.H. The renin angiotensin-aldosterone system (RAAS) in normal man. Conn. Med. 29 10 (1965) 710-711
40. Nahum L.H. The renin-angiotensin-aldosterone system (RAAS) clinical conditions with increased production of renin. Conn. Med. 29 11 (1965) 772-775 (passim)
41. Nanus D.M., Engelstein D., Gastl G.A., Gluck L., Vidal M.J., Morrison M., Finstad C.L., Bander N.H., and Albino A.P. Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A. Proc. Natl. Acad. Sci. U. S. A. 90 15 (1993) 7069-7073
42. Nomura M., Nomura S., Mitsui T., Suzuki M., Kobayashi H., Ito T., Itakura A., Kikkawa F., and Mizutani S. Possible involvement of aminopeptidase A in hypertension and renal damage in Dahl salt-sensitive rats. Am. J. Hypertens. 18 4 Pt 1 (2005) 538-543
43. Nosadini R., and Tonolo G. Blood glucose and lipid control as risk factors in the progression of renal damage in type 2 diabetes. J. Nephrol. 16 Suppl 7 (2003) S42-S47
44. Ofner L.D., and Hooper N.M. The C-terminal domain, but not the interchain disulphide, is required for the activity and intracellular trafficking of aminopeptidase A. Biochem. J. 362 Pt 1 (2002) 191-197
45. Pickering G.W., Prinzmetal M., et al. The effect of renin on urine formation. J. Physiol. 98 3 (1940) 314-335
46. Reiser J., Polu K.R., Moller C.C., Kenlan P., Altintas M.M., Wei C., Faul C., Herbert S., Villegas I., Avila-Casado C., et al. TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat. Genet. 37 7 (2005) 739-744
47. Ross M.J., Martinka S., D'Agati V.D., and Bruggeman L.A. NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy. J. Am. Soc. Nephrol. 16 8 (2005) 2403-2411
48. Schwartz E.J., Cara A., Snoeck H., Ross M.D., Sunamoto M., Reiser J., Mundel P., and Klotman P.E. Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes. J. Am. Soc. Nephrol. 12 8 (2001) 1677-1684
49. Szokol M., Soltesz M., and Varga S. Ultrastructural changes of the rat renal glomeruli in the early phase of renovascular hypertension. Acta Morphol. Acad. Sci. Hung. 27 3 (1979) 117-132
50. Tigerstedt R., and Bergman P.G. Skand. Arch. Physiol. Biochem. 8 (1898) 223
51. Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., and Turner A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275 43 (2000) 33238-33243
52. Walter R., Simmons W.H., and Yoshimoto T. Proline specific endo- and exopeptidases. Mol. Cell. Biochem. 30 2 (1980) 111-127
53. Wang J., Walker H., Lin Q., Jenkins N., Copeland N.G., Watanabe T., Burrows P.D., and Cooper M.D. The mouse BP-1 gene: structure, chromosomal localization, and regulation of expression by type I interferons and interleukin-7. Genomics 33 2 (1996) 167-176
54. Winn M.P., Conlon P.J., Lynn K.L., Farrington M.K., Creazzo T., Hawkins A.F., Daskalakis N., Kwan S.Y., Ebersviller S., Burchette J.L., et al. A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308 5729 (2005) 1801-1804
55. Wolf G., Mentzel S., and Assmann K.J. Aminopeptidase A: a key enzyme in the intrarenal degradation of angiotensin II. Exp. Nephrol. 5 5 (1997) 364-369
56. Wu Q., Lahti J.M., Air G.M., Burrows P.D., and Cooper M.D. Molecular cloning of the murine BP-1/6C3 antigen: a member of the zinc-dependent metallopeptidase family. Proc. Natl. Acad. Sci. U. S. A. 87 3 (1990) 993-997
57. Zini S., Fournie-Zaluski M.C., Chauvel E., Roques B.P., Corvol P., and Llorens-Cortes C. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc. Natl. Acad. Sci. U. S. A. 93 21 (1996) 11968-11973
58. Zuo Y., Matsusaka T., Zhong J., Ma J., Ma L.J., Hanna Z., Jolicoeur P., Fogo A.B., and Ichikawa I. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. J. Am. Soc. Nephrol. 17 10 (2006) 2832-2843